Twin Tree Management, LP Bluebird Bio, Inc. Call Options Transaction History

Twin Tree Management, LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2018 Nov 09, 2018	SELL	$88.86 - $117.49 $488,730 - $646,195	-5,500 Reduced 11.53%	42,200 $6.16 Million
Q2 2018 Aug 08, 2018	BUY	$99.64 - $127.59 $607,804 - $778,299	6,100 Added 14.66%	47,700 $7.49 Million
Q1 2018 May 09, 2018	SELL	$105.8 - $150.94 $423,200 - $603,760	-4,000 Reduced 8.77%	41,600 $7.1 Million
Q4 2017 Feb 09, 2018	BUY	$81.25 - $130.7 $3.71 Million - $5.96 Million	45,600	45,600 $8.12 Million

27M

191K

299K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $561M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.